These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32374692)

  • 1. The Australian Approach to Tobacco Harm Reduction Is Even More Misguided Than the US Approach.
    Wodak A; Mendelsohn CP
    Am J Public Health; 2020 Jun; 110(6):783-784. PubMed ID: 32374692
    [No Abstract]   [Full Text] [Related]  

  • 2. Will E-Cigarette Regulation Evolve in Pace With New Products?
    McKee M
    Am J Public Health; 2020 Jun; 110(6):782-783. PubMed ID: 32374689
    [No Abstract]   [Full Text] [Related]  

  • 3. Placing the Legal Vape Market in the Hands of Big Tobacco.
    Houston AR; Howard A; Sweanor D
    Am J Public Health; 2020 Jun; 110(6):781-782. PubMed ID: 32374694
    [No Abstract]   [Full Text] [Related]  

  • 4. Refining the Food and Drug Administration's Public Communications, Research Priorities, and Policy Evaluation.
    Nadelmann E
    Am J Public Health; 2020 Jun; 110(6):780-781. PubMed ID: 32374699
    [No Abstract]   [Full Text] [Related]  

  • 5. Shortcomings of the Food and Drug Administration Guidance Addressed by Congress 2020 HR 2339.
    Gee RE
    Am J Public Health; 2020 Jun; 110(6):776-777. PubMed ID: 32374703
    [No Abstract]   [Full Text] [Related]  

  • 6. The Food and Drug Administration as Gatekeeper and the Menthol Exemption.
    Berman ML; Jenson D
    Am J Public Health; 2020 Jun; 110(6):775-776. PubMed ID: 32374698
    [No Abstract]   [Full Text] [Related]  

  • 7. Restricting Flavors in ENDS Could Have Repercussions Beyond Youths' Use.
    Erkkila BE; Kovacevic PI; Yach D
    Am J Public Health; 2020 Jun; 110(6):777-778. PubMed ID: 32374691
    [No Abstract]   [Full Text] [Related]  

  • 8. The Food and Drug Administration Is Not Positioned to Deter Adolescent E-Cigarette Use.
    Rodu B
    Am J Public Health; 2020 Jun; 110(6):778-779. PubMed ID: 32374697
    [No Abstract]   [Full Text] [Related]  

  • 9. The Race to a Tobacco Endgame.
    Malone RE
    Tob Control; 2016 Nov; 25(6):607-608. PubMed ID: 28319937
    [No Abstract]   [Full Text] [Related]  

  • 10. Framing the question: electronic cigarettes and harm reduction.
    Ashton J
    J R Soc Med; 2019 Nov; 112(11):485-486. PubMed ID: 31710826
    [No Abstract]   [Full Text] [Related]  

  • 11. Flavored tobacco to E-cigarette's: How the tobacco industry sustains its product flow.
    Raj AT; Patil S; Gupta AA; Suveetha G
    Oral Oncol; 2018 Oct; 85():110. PubMed ID: 30087003
    [No Abstract]   [Full Text] [Related]  

  • 12. Examining the sources of evidence in e-cigarette policy recommendations: A citation network analysis of international public health recommendations.
    Smith MJ; Baxter AJ; Skivington K; McCann M; Hilton S; Katikireddi SV
    PLoS One; 2021; 16(8):e0255604. PubMed ID: 34347823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US plan gives greater role to electronic cigarettes in tobacco harm reduction.
    McCarthy M
    BMJ; 2017 Aug; 358():j3689. PubMed ID: 28765143
    [No Abstract]   [Full Text] [Related]  

  • 14. Why the tobacco industry fears plain packaging.
    Chapman S
    Med J Aust; 2011 Sep; 195(5):255. PubMed ID: 21895581
    [No Abstract]   [Full Text] [Related]  

  • 15. Bridging the divide: a shared interest in a coherent national tobacco policy.
    Parrish SC
    Yale J Health Policy Law Ethics; 2002; 3(1):109-18. PubMed ID: 12825429
    [No Abstract]   [Full Text] [Related]  

  • 16. [The war on smoking: Changing strategic position[Editorial]].
    Beck HJ
    Laeknabladid; 2015 Jan; 101(1):9. PubMed ID: 25682774
    [No Abstract]   [Full Text] [Related]  

  • 17. E-Cigarettes, Harm Reduction, and Tobacco Control: A Path Forward?
    Glynn TJ; Hays JT; Kemper K
    Mayo Clin Proc; 2021 Apr; 96(4):856-862. PubMed ID: 33494956
    [No Abstract]   [Full Text] [Related]  

  • 18. Tobacco litigation: a mid-course review.
    Daynard RA
    Cancer Causes Control; 2001 May; 12(4):383-6. PubMed ID: 11456235
    [No Abstract]   [Full Text] [Related]  

  • 19. Examining the evidence for the health impact of combustion-free products: progress and prospects for tobacco harm reversal and reduction.
    Polosa R
    Intern Emerg Med; 2021 Nov; 16(8):2043-2046. PubMed ID: 34524625
    [No Abstract]   [Full Text] [Related]  

  • 20. Tobacco litigation and legislation.
    Lydiatt DD; Lydiatt WM; Karrer FW; Grasz S
    Head Neck; 2000 Oct; 22(7):643-8. PubMed ID: 11002317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.